Loading…
OKYO Pharma Limited is projected to rise to $2.19 by 2027, a +29% move from its current price of $1.69. OKYO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.65 | $1.69 | $1.73 | +0.03% |
| May 30 | $1.63 | $1.69 | $1.75 | +0.06% |
| May 31 | $1.62 | $1.69 | $1.77 | +0.08% |
| Jun 1 | $1.61 | $1.69 | $1.78 | +0.11% |
| Jun 2 | $1.60 | $1.69 | $1.79 | +0.14% |
| Jun 3 | $1.59 | $1.69 | $1.80 | +0.17% |
| Jun 4 | $1.58 | $1.69 | $1.81 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.58 | $1.69 | $1.81 | +0.19% |
| Week 2 | $1.54 | $1.70 | $1.87 | +0.39% |
| Week 3 | $1.51 | $1.70 | $1.91 | +0.58% |
| Week 4 | $1.49 | $1.70 | $1.95 | +0.78% |
| Week 5 | $1.47 | $1.71 | $1.99 | +0.98% |
| Week 6 | $1.45 | $1.71 | $2.02 | +1.17% |
| Week 7 | $1.43 | $1.71 | $2.05 | +1.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OKYO Pharma Limited is a clinical-stage biopharmaceutical company developing therapeutics for inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
OKYO Pharma Limited (OKYO) is a healthcare stock currently priced at $1.63 with a market cap of $85.54M. It is ranked 4324 among listed equities.
A major floor 14.2% below — a decisive break under it would weaken the trend.
The nearest floor, 10.1% below — buyers have tended to step in here.
Price is pressing into resistance (1.2% away) — a breakout level to watch.
A major ceiling 40.2% above — clearing it would confirm fresh momentum.
Key OKYO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OKYO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.66 | Buy | $1.67 | Buy |
| MA 10 | $1.63 | Buy | $1.65 | Buy |
| MA 20 | $1.63 | Buy | $1.63 | Buy |
| MA 50 | $1.61 | Buy | $1.65 | Buy |
| MA 100 | $1.81 | Sell | $1.76 | Sell |
| MA 200 | $2.01 | Sell | $1.86 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.95 | Neutral |
| Stoch RSI (14) | 83.16 | Sell |
| CCI (20) | 113.48 | Buy |
| Williams %R (14) | -14.29 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 3.68 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 85.71 | Sell |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 64.15 | Neutral |
| Momentum (10) | 0.07 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 1.70 | Sell |
| ADX (14) | 7.40 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical backdrop remains bullish with RSI14 at 50, and key moving averages showing the near-term trend. The SMA50 is $1.61 and the SMA200 is $2.03, with a defined technical texture between support at $1.52 and resistance at $1.68.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.51 | $1.69 | $2.56 | 0% | Neutral | |
| $1.74 | $2.19 | $2.90 | +29% | Bullish | |
| $1.84 | $2.37 | $3.25 | +40% | Bullish | |
| $1.96 | $2.58 | $3.63 | +52% | Bullish | |
| $1.85 | $2.48 | $3.58 | +47% | Bullish | |
| $1.94 | $2.64 | $3.88 | +56% | Bullish | |
| $2.24 | $3.10 | $4.65 | +84% | Bullish | |
| $2.58 | $3.63 | $5.53 | +115% | Bullish | |
| $2.73 | $3.89 | $6.01 | +130% | Bullish | |
| $2.67 | $3.86 | $6.05 | +128% | Bullish | |
| $3.73 | $5.74 | $9.54 | +240% | Bullish | |
| $5.73 | $9.80 | $17.75 | +480% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.51 | $1.69 | $1.99 | +0.00% |
| June 2026 | $1.46 | $1.71 | $2.06 | +1.46% |
| July 2026 | $1.47 | $1.73 | $2.11 | +1.08% |
| August 2026 | $1.54 | $1.84 | $2.26 | +6.01% |
| September 2026 | $1.61 | $1.92 | $2.38 | +4.57% |
| October 2026 | $1.60 | $1.92 | $2.40 | +0.12% |
| November 2026 | $1.62 | $1.95 | $2.45 | +1.44% |
| December 2026 | $1.67 | $2.03 | $2.56 | +3.83% |
Click any year to see its month-by-month OKYO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OKYO price prediction for 2026 points to an average of $1.69 (low $1.51, high $2.56) — a potential gain of 0% on today's $1.69. A consolidation phase looks the most probable path here.
In 2027, OKYO is projected to trade between $1.74 and $2.90, averaging $2.19 — a potential gain of +29% from today's $1.69. That is up +29% on the projected 2026 average. Momentum favours further upside here.
OKYO Pharma Limited's 2028 outlook centres on $2.37, within a $1.84 to $3.25 range. That is up +9% on the projected 2027 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, OKYO could reach as high as $3.63, with a base case around $2.58 and support toward $1.96 — roughly +52% from $1.69. Momentum favours further upside here.
Expect OKYO to range from $1.85 to $3.58 through 2030. The $2.48 average target implies a +47% move from current prices. That is -4% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The OKYO price prediction for 2031 points to an average of $2.64 (low $1.94, high $3.88) — a potential gain of +56% on today's $1.69. Momentum favours further upside here.
In 2032, OKYO is projected to trade between $2.24 and $4.65, averaging $3.10 — a potential gain of +84% from today's $1.69. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
OKYO Pharma Limited's 2033 outlook centres on $3.63, within a $2.58 to $5.53 range. That is up +17% on the projected 2032 average. That marks a +115% change versus current levels. Momentum favours further upside here.
By 2034, OKYO could reach as high as $6.01, with a base case around $3.89 and support toward $2.73 — roughly +130% from $1.69. Buyers look set to stay in control over this stretch.
Expect OKYO to range from $2.67 to $6.05 through 2035. The $3.86 average target implies a +128% move from current prices. That is -1% versus the projected 2034 average. Momentum favours further upside here.
The OKYO price prediction for 2040 points to an average of $5.74 (low $3.73, high $9.54) — a potential gain of +240% on today's $1.69. Buyers look set to stay in control over this stretch.
In 2050, OKYO is projected to trade between $5.73 and $17.75, averaging $9.80 — a potential gain of +480% from today's $1.69. That is up +71% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OKYO today (≈ 591.715976 OKYO) could be worth
$5,795.87
+$4,795.87 (+480%) by 2050 · US Dollar
Based on the average projected OKYO price of $9.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OKYOwould be worth at today's price.
$1,000 invested in OKYO on May 27, 2025 (≈ 571.428571 OKYO) would be worth
$965.71
-$34.29 (-3.4%) today · 0.97× · US Dollar
Based on a OKYO entry price of $1.75 vs. today's $1.69.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.6 | $1,056.25 | +5.6% |
| 1 month ago | $1.58 | $1,069.62 | +7.0% |
| 3 months ago | $1.72 | $982.56 | -1.7% |
| 6 months ago | $1.96 | $862.24 | -13.8% |
| 1 year ago | $1.75 | $965.71 | -3.4% |
| All time (4.0y) ago | $3.62 | $466.85 | -53.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OKYO forecast.
Our base-case forecast reaches $3.40 around 2033.
Implied market cap at $3.40: $178.43M
The multi-year forecast shows a bullish trajectory beyond 2026, with the 2026 average price at $1.63 and expanding through the decade. The forecast climbs to a 2027 average of $2.03 (ROI 24.3%), 2028 $2.18 (ROI 33.7%), 2029 $2.31 (ROI 42%), and 2030 $2.16 (ROI 32.8%), followed by 2031 $2.25 (ROI 38.3%), 2032 $2.56 (ROI 56.9%), 2033 $2.95 (ROI 80.9%), 2034 $3.18 (ROI 95.3%), and 2035 $3.14 (ROI 92.6%). The longer horizon shows 2040 at $4.44 (ROI 172.5%) and 2050 at $7.19 (ROI 341.2%), with corresponding max values of $7.35 in 2040 and $12.96 in 2050, all under a bullish sentiment.
Tap a question to reveal the answer.
Average price in 2030 is $2.16 with a min of $1.62 and a max of $3.11. The forecast implies a 32.8% ROI and Bullish sentiment in 2030.
Forecasts show a bullish trajectory beyond 2026, with rising averages and notable ROI: 2027 avg $2.03 (ROI 24.3%), 2032 avg $2.56 (ROI 56.9%), 2033 avg $2.95 (ROI 80.9%), and 2050 avg $7.19 (ROI 341.2%). These are estimates, not guarantees.
Yes, the max values in the forecast exceed $5, with 2040 max $7.35 and 2050 max $12.96.
Current price is $1.63 and market cap is $85.54M.
The 30-day price range is from $1.38 to $1.93.
OKYO Pharma Limited Community Discussion
0Share your OKYO Pharma Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.